Joanne Curley

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joanne Curley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vera Therapeutics, Inc. Chief Development Officer Class A Common Stock 26,962 $485,316 $18.00 21 Aug 2023 Direct
Vistagen Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 17,600 09 Sep 2025 Direct

Insider Reports Filed by Joanne Curley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 09 Sep 2025 1 $0 4 Director 11 Sep 2025, 18:14
VTGN Vistagen Therapeutics, Inc. 06 Sep 2024 1 $0 4 Director 10 Sep 2024, 17:00
VTGN Vistagen Therapeutics, Inc. 04 Mar 2024 1 $0 4 Director 06 Mar 2024, 18:00
VERA Vera Therapeutics, Inc. 21 Aug 2023 1 -$24,817 4 Chief Development Officer 23 Aug 2023, 17:57
VERA Vera Therapeutics, Inc. 15 Feb 2023 1 $0 4 Chief Development Officer 17 Feb 2023, 15:12
VERA Vera Therapeutics, Inc. 16 Dec 2022 5 -$36,708 4 Chief Development Officer 19 Dec 2022, 16:01
VERA Vera Therapeutics, Inc. 12 Dec 2022 9 -$148,140 4 Chief Development Officer 14 Dec 2022, 15:08
VERA Vera Therapeutics, Inc. 07 Dec 2022 1 -$8,136 4 Chief Development Officer 08 Dec 2022, 15:06
VERA Vera Therapeutics, Inc. 17 Nov 2022 6 -$38,853 4 Chief Development Officer 21 Nov 2022, 15:08
VERA Vera Therapeutics, Inc. 09 Nov 2022 1 -$8,171 4 Chief Development Officer 10 Nov 2022, 15:04
VERA Vera Therapeutics, Inc. 18 Oct 2022 11 -$95,157 4 Chief Development Officer 20 Oct 2022, 16:37
VERA Vera Therapeutics, Inc. 05 Oct 2022 1 -$21,380 4 Chief Development Officer 06 Oct 2022, 16:04
VERA Vera Therapeutics, Inc. 20 Sep 2022 20 -$186,211 4 Chief Development Officer 22 Sep 2022, 16:06
VERA Vera Therapeutics, Inc. 07 Sep 2022 1 -$18,406 4 Chief Development Officer 08 Sep 2022, 16:41
VERA Vera Therapeutics, Inc. 19 Aug 2022 21 -$91,959 4 Chief Development Officer 23 Aug 2022, 16:15
VERA Vera Therapeutics, Inc. 03 Aug 2022 1 -$16,608 4 Chief Development Officer 04 Aug 2022, 16:07
VERA Vera Therapeutics, Inc. 19 Jul 2022 10 -$131,384 4 Chief Development Officer 20 Jul 2022, 16:08
VERA Vera Therapeutics, Inc. 14 Jul 2022 4 -$119,457 4 Chief Development Officer 15 Jul 2022, 16:41
VERA Vera Therapeutics, Inc. 07 Jul 2022 7 -$113,052 4 Chief Development Officer 11 Jul 2022, 16:04
VERA Vera Therapeutics, Inc. 22 Jun 2022 4 -$15,302 4 Chief Development Officer 23 Jun 2022, 18:49
VERA Vera Therapeutics, Inc. 17 Jun 2022 7 -$70,309 4 Chief Development Officer 21 Jun 2022, 20:16
VERA Vera Therapeutics, Inc. 31 May 2022 3 -$3,537 4 Chief Development Officer 02 Jun 2022, 16:06
VTGN VistaGen Therapeutics, Inc. 01 Mar 2022 1 $0 4 Director 03 Mar 2022, 15:10
VERA Vera Therapeutics, Inc. 16 Feb 2022 1 $0 4 Chief Development Officer 18 Feb 2022, 15:12
VERA Vera Therapeutics, Inc. 13 May 2021 1 $0 4 Chief Development Officer 17 May 2021, 20:32
VERA Vera Therapeutics, Inc. 13 May 2021 0 $0 3 Chief Development Officer 13 May 2021, 19:08